
Update on the HTA Coordination Group subgroup meetings held on April 25 and 26.
Their collective efforts will surely shape the HTA landscape in the long run.
Recent Posts
Biomarin Withdraws Voxzogo Reimbursement Application in the Netherlands
Voxzogo reimbursement Netherlands hangs in limbo after Biomarin's decision on March 12, 2026, to withdraw its application, leaving children with achondroplasia without access despite parental pleas.
Catalyzing Cardiovascular Health Innovation through Urban Interventions and Collaborative Research
Cardiovascular health innovation is at the forefront of the Innovative Health Initiative (IHI), the world's largest public-private partnership in life sciences, which succeeds the Innovative Medicines Initiative (IMI). Key projects from IHI Call 8, such as Cities@Heart, target cardiovascular dise...
EMA Approval Submission for Teclistamab Multiple Myeloma Monotherapy
Johnson & Johnson has submitted a Type II variation application to the European Medicines Agenc...